NRXP NRX Pharmaceuticals
NRX Pharmaceuticals earnings company data as of 4:48 AM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
2 periods, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 13 Nov | EPS | — | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 14 Aug | EPS | — | — | — |
| Rev | — | — | — |
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | FORM 10-Q | Filing Doc | |
| 8-K | 7.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 8-K | 1.01,8.01,9.01 | Filing Doc | |
| 424B5 | FORM 424B5 | Filing Doc | |
| 424B5 | FORM 424B5 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | FORM 10-Q | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| 10-K | FORM 10-K | Filing Doc | |
| DEFA14A | FORM DEFA14A | Filing Doc | |
| DEF 14A | FORM DEF 14A | Filing Doc | |
| 424B5 | FORM 424B5 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 8-K | 3.01,7.01,8.01,9.01 | Filing Doc | |
| 8-K | 7.01,9.01 | Filing Doc | |
| 424B3 | FORM 424B3 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.